ORIGINAL ARTICLE


Acesso aberto Revisado por pares

0

Visualização

Efficacy and safety of paliperidone palmitate 3-month formulation in Latin American patients with schizophrenia: A subgroup analysis of data from two large phase 3 randomized, double-blind studies

Adam J. Savitz1, Haiyan Xu1, Srihari Gopal1, Isaac Nuamah1, Maju Mathews2, Bernardo Soares3

DOI: 10.1590/1516-4446-2018-0153

Vol.41 Issue 6/2019:

1Janssen Research & Development, LLC, Pennington, NJ, USA
2Janssen Research & Development, LLC, Titusville, NJ, USA
3Janssen-Cilag UK, Buckinghamshire, UK

Corresponding author

Adam J. Savitz, Janssen Research & Development, LLC, 1800 American Boulevard, Pennington, NJ, USA.
E-mail: asavitz@its.jnj.com


© 2026 All rights reserved